Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yildiz Yildiz, Heidrun Matern, Bonne Thompson, Jeremy C. Allegood, Rebekkah L. Warren, Denise M.O. Ramirez, Robert E. Hammer, F. Kent Hamra, Siegfried Matern, David W. Russell
Published in Volume 116, Issue 11
J Clin Invest. 2006; 116(11):2985–2994 doi:10.1172/JCI29224
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Characterization of Gba2–/– mice.

(A) PCR genotyping of Gba2 wild-type, heterozygous (+/–), and homozygous genomic DNA. A 640-bp product was generated from the mutant allele, while a 530-bp product was produced from the wild-type allele. (B) Immunoblotting of GBA2 protein levels in pooled brains, testes, and livers from Gba2 wild-type, heterozygous, and homozygous mice (n = 6 per genotype). The filter of the upper blot was stripped of antibody-antigen complexes and reprobed with an antiserum recognizing calnexin to serve as a loading control. (C) Bile acid glucosidase and transferase enzyme activities were determined in the brains, testes, and livers of Gba2 wild-type, heterozygous, and homozygous mice. “X” in the reaction shown is either dolichyl phosphoglucose or octyl β-glucoside.